Chemistry, systems and methods of translocation of a polymer through a nanopore

Abstract

Embodiments disclosed herein are directed to recognition tunneling systems, methods and devices, and more particularly, to chemical reactions for selectively labeling proteins and peptides and placing protein and/or peptides into, or onto a nanopore formed in a solid support and threading such in and/or through the nanopore, with such nanopores, in some embodiments, including a molecular motor to pull or otherwise force the protein/peptide through the nanopore.

Claims

1. A method, comprising: attaching a polymer containing one or more charged residues to only an N terminus of a protein or peptide to be identified and/or sequenced to generate a modified protein or peptide, wherein the rest of the protein or peptide remains unmodified; applying a voltage or an electric current to thread the modified protein or peptide into a nanopore of an identification or sequencing apparatus, the polymer containing one or more charged residues of the modified protein or peptide being pulled into the nanopore before the rest of the modified protein or peptide; moving the modified protein or peptide through the nanopore; and reading the sequence of the protein or peptide by means of electrical signals generated as the modified protein or peptide passes between a gap in a pair of electrodes.

2. The method of claim 1, wherein the polymer is a peptide.

3. The method of claim 1, wherein moving is established at least in part via a molecular motor.

4. The method of claim 2, wherein the peptide incorporates a targeting motif for threading a molecular motor.

5. The method of claim 1, further comprising attaching a reactive alkyne group at the N terminus of the protein or peptide prior to the attachment of the polymer containing one or more charged residues.

6. The method of claim 1, further comprising attaching a bromoacetyl group at the N terminus of the protein or peptide prior to the attachment of the polymer containing one or more charged residues.

7. The method of claim 1, the one or more charged residues being in a pH range from about 3 to about 8.

Description

BRIEF DESCRIPTION OF THE FIGURES

(1) FIG. 1 illustrates the coupling of a protein or peptide to be sequenced to a threader molecule, according to some embodiments of the present disclosure.

(2) FIG. 2 illustrates use of a charged threader molecule to force (e.g., pull) a protein or peptide into a nanopore (e.g., contact with) of a recognition tunneling apparatus that incorporates reading electrodes, according to some embodiments of the present disclosure.

(3) FIG. 3 illustrates a spontaneous threading of a molecular motor by a targeting sequence on the threader molecule, according to some embodiments of the present disclosure.

(4) FIG. 4 illustrates a biasing arrangement for reading a recognition tunneling signal from each amino acid residue in a recognition tunneling apparatus (for example), according to some embodiments of the present disclosure.

(5) FIG. 5 illustrates the reading out of a sequence of a protein/peptide (SEQ ID NO: 12) as the molecular motor forces (e.g., pulls) a threader and protein or peptide through the nanopore, according to some embodiments of the disclosure.

DETAILED DESCRIPTION OF SOME OF THE EMBODIMENTS

(6) Before some embodiments of the present disclosure are described in detail, it is to be understood that such embodiments are not limited to particular variations set forth and may, of course, vary. Various changes may be made to embodiments described and equivalents may be substituted without departing from the true spirit and scope of inventions disclosed herein. In addition, many modifications may be made to adapt a particular situation, material, composition of matter, process, process act(s) or step(s), to the objective(s), spirit or scope of the present disclosure. All such modifications are intended to be within the scope of any and all claims supported by the present disclosure.

(7) Methods recited herein may be carried out in any order of the recited events which is logically possible, as well as the recited order of events. Furthermore, where a range of values is provided, it is understood that every intervening value, between the upper and lower limit of that range and any other stated or intervening value in that stated range is encompassed within embodiments of the disclosure. Also, it is contemplated that any optional feature of one and/or another of the disclosed embodiments described herein may be set forth and claimed independently, or in combination with any one or more of the features described herein.

(8) Reference to a singular item, includes the possibility that there are plural of the same items present. More specifically, as used herein and in the appended claims, the singular forms “a,” “and,” “said” and “the” include plural referents unless the context clearly dictates otherwise. It is further noted that the claims may be drafted to exclude any optional element. As such, this statement is intended to serve as antecedent basis for use of such exclusive terminology as “solely,” “only” and the like in connection with the recitation of claim elements, or use of a “negative” limitation. Unless defined otherwise herein, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.

(9) In some embodiments, the following reaction is provided for enabling recognition tunneling to achieve sequencing of one or more unknown proteins.

(10) First, Pentynoic Anhydride (see Scheme 1, below) is dissolved in acetonitrile to a concentration of 1 mM, and a peptide to be sequenced is dissolved in acetate buffer. The pH of the peptide/acetate solution is adjusted to between about 5.0 and about 7.6. In some embodiments, the pH for the peptide/acetate solution is adjusted to about 5.5. The two solutions are preferably held at about 0° C., where they are mixed and maintained at about 0° C. for, in some embodiments, about 10 minutes to about 5 hours. In some embodiments, the two solutions are mixed and maintained at about 0° C. for about two (2) hours.

(11) In some embodiments, the starting peptide is converted to a peptide modified with alkyne at its N-terminus as shown in Scheme 1 without any modifications on the primary amines of the lysine side chains.

(12) ##STR00001##

(13) Alkynylation of the N terminus of a peptide (i.e., the wavy line on product at right—the terminal unmodified lysine is shown) may be completed, for example, by reacting with pentynoic anhydride (above arrow, 2 in FIG. 1). The chemistry was tested on the peptide shown on the left.

(14) In some embodiments, a faster reaction can occur if bromoacetic acid is used rather than pentynoic anhydride (see Scheme 2, below). The product is a peptide with a bromo-acetylated —N terminus, which may be readily coupled to a polyionic threader molecule by reaction with a thiol. In such embodiments, the reaction can be completed in about 20 minutes, using (for example) the conditions described above.

(15) ##STR00002##

(16) Bromo acetylation of the N terminus of any peptide (i.e., the wavy line on product at right—the terminal unmodified lysine is shown) may be completed, for example, by reacting with bromoacetyl anhydride (above arrow).

(17) A protein or peptide to be sequenced, once modified as described above, can be attached or linked to a polyionic therader molecule. In some embodiments, it may be advantageous to use a charged peptide as the polyionic threader molecule (see Nivala et al.)..sup.1 In particular, in some embodiments, the threader molecule can be synthesized to contain a reactive group (e.g., such as an azide or thiol) at one end to bind to the protein/peptide to be sequenced, and a targeting motif, such as a peptide sequence, designed to bind a molecular motor (protein motor, for example) that can be used to pull the protein through a nanopore (see Id., Nivala et al.). In some embodiments, in the case of the ClpX motor used by Nivala et al., the targeting motif for threading the molecular motor is AANDENYALLA (SEQ ID NO: 4), for example. The polyionic component of the threader molecule can be any non-folding sequence that contains a number of charged residues. For example, the sequence used by Nivala et al. was:

(18) TABLE-US-00001 (SEQ ID NO: 7) GGSSGGSGGSGSSGDGGSSGGSGGSGSSG DGGSSGGSGGDGSSGDGGSDGDSDGSDGD GDSDGDD
The 10 aspartic acid residues are negatively charged at neutral pH and provide the charge that can be used to drag this tail into the nanopore.

(19) In some embodiments, the threader molecule comprises the following sequence comprising the polyionic component and the targeting motif shown above:

(20) TABLE-US-00002 (SEQ ID NO: 8) GGSSGGSGGSGSSGDGGSSGGSGGSGSSG DGGSSGGSGGDGSSGDGGSDGDSDGSDGD GDSDGDDAANDENYALAA

(21) In some embodiments, a standard solid phase peptide synthesis can be used to place an azide at the end of GGSSGGSGGSGSSGDGGSSGGSGGSGSS GDGGSSGGSGGDGSSGDGGSDGDSDGSDGDGDSDGDDAANDENYALAA (SEQ ID NO: 8) 3 to form a standard (I) reagent, such as a polyionic threader molecule, for binding to a protein containing a reactive group, such as an alkyne or a bromoacetyl group, using the click chemistry described above (for example). Note that, because the threader molecule (I) does not contain any lysines, no special reaction conditions are required to produce this threader molecule (according to some embodiments).

(22) TABLE-US-00003 I- an azide containing threading peptide (SEQ ID NO: 9) N.sub.3GGSSGGSGGSGSSGDGGSSGGSGGSGSS GDGGSSGGSGGDGSSGDGGSDGDSDGSDG DGDSDGDDAANDENYALAA I—an azide containing threading peptide

(23) In some embodiments of the present disclosure, the azide (N.sub.3) containing peptide I is coupled to the alkyne terminated “unknown” protein or peptide as modified with an alkyne (e.g., Scheme 1).

(24) Alternatively, in some embodiments, the peptide can be synthesized with a cysteine residue at the N terminus (II):

(25) TABLE-US-00004 II- a cysteine terminated threading peptide (SEQ ID NO: 10) CGGSSGGSGGSGSSGDGGSSGGSGGSGSS GDGGSSGGSGGDGSSGDGGSDGDSDGSDG DGDSDGDDAANDENYALAA II—a cysteine terminated threading peptide

(26) This peptide (II), in some embodiments, can be readily coupled to the bromine terminated “unknown” protein or peptide (e.g., Scheme 2).

(27) Thus, according to some embodiments, a charged polyionic tail is readily ligated to an unknown protein. In particular, peptides carrying charge and sequences that assemble onto a molecular motor may be readily coupled to the N terminus of any protein or peptide that has an exposed N terminus.

EXAMPLE

Sequencing a Protein of Unknown Composition

(28) Referring to FIGS. 1-5, the workflow for a single-molecule protein sequencing run, according to some embodiments, is described. For example, in FIG. 1, an unknown protein 1 is dissolved into aqueous acetate buffer, adjusted to a pH of between about 5.0 and about 7.6, but preferably, in some embodiments, to a pH of about 5.5. Pentynoic Anhydride (e.g., see Scheme 1 and inset in FIG. 1) is dissolved in acetonitrile to a concentration of about 1 mM, in some embodiments, but this can be between about 10 nM and about 100 mM (for example). The two solutions, held at about 0° C., for example, are mixed and maintained at about 0° C. for about 10 minutes to about 5 hours, but preferably, in some embodiments, to about 2 hours. The result, in some embodiments, is the addition of a reactive alkyne group (symbolized by the arrow head comprising 2 at the N terminus of the protein but not at other sites. It will be appreciated by one of skill in the art, that, according to some embodiments, the same process can be carried out using peptides obtained from the unknown protein by a Trypsin digest. Such a digest may be essential in cases where the N-terminus of the protein is buried in the body of the protein, thereby making it unaccessible to the Pentynoic Anhydride without a digest. The protein, 1, thus modified may then be coupled to reactive end of a threader molecule 3. This reactive end may be an azide group or a thiol. The result is the coupled system of unknown protein and threader molecule 6.

(29) In some embodiments, the threader molecule can consist of two parts. For example, the first part 4 (polyionic component) is a charged peptide that does not fold into a fixed secondary structure, for example the sequence:

(30) TABLE-US-00005 (SEQ ID NO: 11) GGSSGGSGGSGSSGDGGSSGGSGGSGSSG DGGSSGGSGGDGSSGDGGSDGDSDGSDGD GDSDGDD
Note, the N terminus of the sequence shown is modified (for example) to contain an azide or a thiol.

(31) The second part 5 may be a sequence (targeting motif) designed to thread the molecular motor. In the case of ClpX, this may be an 11 aa ClpX targeting motif: AANDENYALAA (SEQ ID NO: 4). It will be appreciated by one of skill in the art that the same ends can be achieved using the thiol-bromo reaction described in Scheme 2 (for example).

(32) Once the complex 6 is formed, it can be dissolved into a suitable salt solution, e.g., KCl, NaCl or any other mono or divalent salt such as MgCl.sub.2 included in the solution if required for the operation of a molecular motor, at concentrations from about 1 mM to about 1M. Accordingly, once in the salt solution, molecules can then be drawn into a nanopore 20 (provided on e.g., substrate 21) using electrophoresis as shown in the recognition tunneling apparatus shown in FIG. 2. For example, if the charges on the threader molecule are negative, then the molecules will be pulled into the pore by using a bias applied between a positive reference electrode 25 on the input side of the pore 20 and the negative reference electrode 24. If the protein or peptide 6 is folded, it will stop at the entrance to the pore, so long as, in some embodiments, the applied bias V is small. Suitable values may include 5 mV to 500 mV.

(33) In some embodiments, the nanopore may be modified to have a pair of electrodes 22 accessible to the amino acid residues. In some embodiments, these electrodes may be Pd or Pt with a gap of between about 2 to about 4 nm, as described in pending PCT application no. PCT/US2013/032240, the entire disclosure of which is herein incorporated by reference. The electrodes may be functionalized with reader molecules 23 that strongly bind to the metal and form transient, non-covalent contacts with the target amino acid residues. In some embodiments, the molecule may be the imidazole carboxamide shown inset in FIG. 2 (for example).

(34) Accordingly, with the protein or peptide 6 stalled in this position, and about 1 nM to about 1 mM (but in some embodiments about 100 nM) ClpX (or other motor protein) 30 introduced into the output side of the nanopore (FIG. 3), the motor protein threads the motor targeting motif (5 in FIG. 1).

(35) Referring to FIG. 4, a bias V applied via biasing means 41 may be applied across the junction while the current through the molecular complex in the junction is read/determined by current monitor 42. This current signal may be used to identify the amino acid residue in the gap, e.g., as described in PCT application no. PCT/US2013/024130, entitled, “Systems, Apparatuses and Methods for Reading an Amino Acid Sequence,” the entire disclosure of which is herein incorporated by reference.

(36) In some embodiments, when ATP (for example) is added to the solution on the output side (e.g., at a concentration of about 1 nM to about 100 mM, but preferably about 1 mM) the motor begins to pull the protein or peptide through the tunnel gap, one residue at a time (for example), as shown in FIG. 5, resulting is a readout/determination of the sequence by means of a computer 43, for example, that determines the characteristic current signals detected by current monitor 42, generated as each residue in turn is trapped in the gap, by, for example, comparing the detected signals against a database of polymer signal signatures (bias means 41, as well as other sensors, devices, databases, and the like, may be in communication or otherwise connected to computer 43).

(37) Any and all references to publications or other documents, including but not limited to, patents, patent applications, articles, webpages, books, etc., presented in the present application, are herein incorporated by reference in their entirety, except insofar as the subject matter may conflict with that of the embodiments of the present disclosure (in which case what is present herein shall prevail). The referenced items are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that any invention disclosed herein is not entitled to antedate such material by virtue of prior invention.

(38) Although example embodiments of the devices, systems and methods have been described herein, other modifications are possible. As noted elsewhere, these embodiments have been described for illustrative purposes only and are not limiting. Other embodiments are possible and are covered by the disclosure, which will be apparent from the teachings contained herein. Thus, the breadth and scope of the disclosure should not be limited by any of the above-described embodiments but should be defined only in accordance with claims supported by the present disclosure and their equivalents. In addition, any logic flow depicted in the above disclosure and/or accompanying figures may not require the particular order shown, or sequential order, to achieve desirable results. Moreover, embodiments of the subject disclosure may include methods, systems and devices which may further include any and all elements from any other disclosed methods, systems, and devices, including any and all elements corresponding to polymer translocation. In other words, elements from one and/or another disclosed embodiment may be interchangeable with elements from other disclosed embodiments. In addition, one or more features/elements of disclosed embodiments may be removed and still result in patentable subject matter (and thus, resulting in yet more embodiments of the subject disclosure). In addition, some embodiments of the present disclosure are distinguishable from the prior art for expressly not requiring one and/or another features disclosed in the prior art (e.g., some embodiments may include negative limitations). Other implementations of some of the embodiments disclosed herein are within the scope of at least some of the following claims of the numerous claims which are supported by the present disclosure which may be presented.

REFERENCES

Herein Incorporated by Reference in their Entireties

(39) 1 Nivala, J., Marks, D. B. & Akeson, M. Unfoldase-mediated protein translocation though an alpha-hemolysin pore. Nature Biotechnol. doi: 10.138/nbt.2503 (2013). 2 Rodriguez-Larrea, D. & Bayley, H. Multistep protein unfolding during nanopore translocation. Nature Nanotechnology 8, 288-295 (2013). 3 Kolb, H. C., Finn, M. G. & Sharpless, K. B. Click Chemistry: Diverse Chemical Function from a Few Good Reactions. Angew. Chem. Int. Ed. 40, 2004-2021 (2001). 4 Hall, A. R. et al. Hybrid pore formation by directed insertion of alpha hemolysin into solid-state nanopores. Nature Nanotechnology 5, 874-877 (2010).